Redwood Investment Management LLC boosted its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 106.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,541 shares of the company's stock after purchasing an additional 4,915 shares during the period. Redwood Investment Management LLC's holdings in Procter & Gamble were worth $1,626,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Nuveen LLC purchased a new position in Procter & Gamble in the first quarter valued at about $1,954,941,000. GAMMA Investing LLC grew its holdings in shares of Procter & Gamble by 20,758.5% in the 1st quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock worth $1,355,087,000 after acquiring an additional 7,913,335 shares during the period. Price T Rowe Associates Inc. MD raised its holdings in Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock worth $3,660,737,000 after purchasing an additional 2,466,308 shares during the last quarter. Invesco Ltd. boosted its position in Procter & Gamble by 19.8% during the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock worth $2,299,580,000 after purchasing an additional 2,228,151 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Procter & Gamble by 15.8% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 16,274,563 shares of the company's stock valued at $2,728,430,000 after purchasing an additional 2,224,912 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company's stock.
Analyst Upgrades and Downgrades
A number of equities research analysts recently issued reports on the company. Redburn Partners set a $161.00 target price on Procter & Gamble in a research note on Thursday, May 1st. BNP Paribas reiterated an "outperform" rating and set a $177.00 price target on shares of Procter & Gamble in a report on Friday, August 15th. JPMorgan Chase & Co. reiterated a "neutral" rating and set a $170.00 target price (down from $178.00) on shares of Procter & Gamble in a research report on Friday, July 25th. Redburn Atlantic downgraded shares of Procter & Gamble from a "buy" rating to a "neutral" rating and set a $161.00 price objective for the company. in a research note on Thursday, May 1st. Finally, Barclays set a $164.00 price objective on shares of Procter & Gamble and gave the stock an "equal weight" rating in a report on Thursday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have given a Hold rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $175.12.
Get Our Latest Stock Analysis on Procter & Gamble
Procter & Gamble Trading Up 1.0%
NYSE PG traded up $1.48 during mid-day trading on Friday, hitting $157.13. The company's stock had a trading volume of 5,317,408 shares, compared to its average volume of 6,701,783. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. Procter & Gamble Company has a 52-week low of $149.91 and a 52-week high of $180.43. The stock's fifty day simple moving average is $156.55 and its two-hundred day simple moving average is $162.55. The firm has a market capitalization of $368.07 billion, a P/E ratio of 24.14, a price-to-earnings-growth ratio of 4.11 and a beta of 0.37.
Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.06. The company had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business's quarterly revenue was up 1.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Research analysts expect that Procter & Gamble Company will post 6.91 EPS for the current year.
Procter & Gamble Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were paid a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date was Friday, July 18th. Procter & Gamble's payout ratio is currently 64.98%.
Insider Buying and Selling
In other Procter & Gamble news, CEO Jennifer L. Davis sold 8,596 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,351,892.92. Following the completion of the transaction, the chief executive officer owned 64,991 shares in the company, valued at $10,221,134.57. This represents a 11.68% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Susan Street Whaley sold 1,000 shares of the stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $156.84, for a total transaction of $156,840.00. Following the completion of the sale, the insider directly owned 28,436 shares of the company's stock, valued at $4,459,902.24. This trade represents a 3.40% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 120,181 shares of company stock valued at $18,918,012. 0.18% of the stock is owned by insiders.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report